An integrated computational workflow for efficient and quantitative modeling of renin inhibitors.

A new integrated computational workflow that couples the strength of the molecular overlay methods to achieve rapid and automated alignments along with 3D-QSAR techniques like CoMFA and CoMSIA for quantitative binding affinity prediction is presented. The results obtained from such techniques are compared with rule-based Topomer CoMFA method, where possible. The developed 3D-QSAR models were prospectively used to predict the affinities of new compounds designed through R-group deconvolution starting from the core chemical scaffold and subsequent virtual combinatorial library enumeration. The general applicability of the seamless in silico modeling workflow is demonstrated using several datasets reported for small molecule inhibitors of renin.

[1]  Ajay N. Jain,et al.  Molecular Shape and Medicinal Chemistry: A Perspective , 2010, Journal of medicinal chemistry.

[2]  R. Sedrani,et al.  Direct renin inhibitors as a new therapy for hypertension. , 2010, Journal of medicinal chemistry.

[3]  M. Grütter,et al.  The crystal structures of recombinant glycosylated human renin alone and in complex with a transition state analog inhibitor. , 1991, Journal of structural biology.

[4]  John P. Overington,et al.  Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation. , 2010, Drug discovery today.

[5]  Serdar Durdagi,et al.  Development of accurate binding affinity predictions of novel renin inhibitors through molecular docking studies. , 2010, Journal of molecular graphics & modelling.

[6]  L. Prade,et al.  Piperidine-based renin inhibitors: upper chain optimization. , 2010, Bioorganic & medicinal chemistry letters.

[7]  R. Cramer,et al.  Topomer CoMFA: a design methodology for rapid lead optimization. , 2003, Journal of medicinal chemistry.

[8]  N. Powell,et al.  Benzyl ether structure-activity relationships in a series of ketopiperazine-based renin inhibitors. , 2005, Bioorganic & medicinal chemistry letters.

[9]  N. Powell,et al.  Equipotent activity in both enantiomers of a series of ketopiperazine-based renin inhibitors. , 2005, Bioorganic & medicinal chemistry letters.

[10]  Richard D. Cramer,et al.  Rethinking 3D-QSAR , 2010, J. Comput. Aided Mol. Des..

[11]  Christoph A. Sotriffer,et al.  Virtual screening : principles, challenges, and practical guidelines , 2011 .

[12]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[13]  Nicolas Foloppe,et al.  Drug-like Bioactive Structures and Conformational Coverage with the LigPrep/ConfGen Suite: Comparison to Programs MOE and Catalyst , 2010, J. Chem. Inf. Model..

[14]  L. Prade,et al.  Design and optimization of new piperidines as renin inhibitors. , 2010, Bioorganic & medicinal chemistry letters.

[15]  Wei Zhao,et al.  Design and optimization of renin inhibitors: Orally bioavailable alkyl amines. , 2009, Bioorganic & medicinal chemistry letters.

[16]  David E. Shaw,et al.  PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results , 2006, J. Comput. Aided Mol. Des..

[17]  C. Bayly,et al.  Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension. , 2010, Bioorganic & medicinal chemistry letters.

[18]  C. Oefner,et al.  Substituted piperidines--highly potent renin inhibitors due to induced fit adaptation of the active site. , 1999, Bioorganic & medicinal chemistry letters.

[19]  G. Klebe,et al.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.

[20]  Jonas Boström,et al.  Assessing the performance of OMEGA with respect to retrieving bioactive conformations. , 2003, Journal of molecular graphics & modelling.

[21]  L. Prade,et al.  New classes of potent and bioavailable human renin inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[22]  Wei Zhao,et al.  Optimization of orally bioavailable alkyl amine renin inhibitors. , 2010, Bioorganic & medicinal chemistry letters.

[23]  J. A. Grant,et al.  A fast method of molecular shape comparison: A simple application of a Gaussian description of molecular shape , 1996, J. Comput. Chem..

[24]  L. Prade,et al.  Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors. , 2009, Journal of medicinal chemistry.

[25]  M. Kansy,et al.  Piperidine-renin inhibitors compounds with improved physicochemical properties. , 1999, Bioorganic & medicinal chemistry letters.

[26]  Jitender Verma,et al.  3D-QSAR in drug design--a review. , 2010, Current topics in medicinal chemistry.

[27]  Ajay N. Jain,et al.  Ligand-based structural hypotheses for virtual screening. , 2004, Journal of medicinal chemistry.

[28]  Hans Matter,et al.  Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds. , 2011, Bioorganic & medicinal chemistry letters.

[29]  N. Powell,et al.  Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors. , 2007, Bioorganic & medicinal chemistry.

[30]  B. Musafia,et al.  Biasing conformational ensembles towards bioactive-like conformers for ligand-based drug design , 2010, Expert opinion on drug discovery.

[31]  J. Falgueyret,et al.  Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines. , 2011, Bioorganic & medicinal chemistry letters.

[32]  Benjamin A. Ellingson,et al.  Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database , 2010, J. Chem. Inf. Model..

[33]  Hans Matter,et al.  Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors. , 2010, Bioorganic & medicinal chemistry letters.

[34]  Ketopiperazine-based renin inhibitors: optimization of the "C" ring. , 2006, Bioorganic & medicinal chemistry letters.

[35]  J. Falgueyret,et al.  Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines. , 2011, Bioorganic & medicinal chemistry letters.